Forty-three of 44 providers interviewed by KLAS said they would buy tomosynthesis again despite the additional time it takes and the unpredictable reimbursement. This and other findings are available in the new KLAS report Breast Tomosynthesis 2013: The Business Case.
To learn more about the breast tomosynthesis vendors and findings in this study, check out the full report, Breast Tomosynthesis 2013: The Business Case. This report is available to health care providers at a significant discount. To purchase, click here.